Navigation Links
Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit

Drug safety firm BioSoteria, Inc. honored Dr. Hugh H. Tilson with the first PDSS Leadership Award at the 3rd Annual Pacific Drug Safety Summit, which took place last Friday in San Francisco. Dr. Tilson, an internationally acclaimed epidemiologist and outcomes researcher, was the moderator of the event and serves as Chairman of BioSoteria's Board of Advisors.

Emeryville, CA (PRWEB) September 30, 2009 -- BioSoteria, Inc., a drug safety services and training firm, honored Hugh H. Tilson, MD, DrPH, with the first PDSS Leadership Award at the 3rd Annual Pacific Drug Safety Summit, which took place last Friday in San Francisco. Dr. Tilson was the moderator of the event and serves as Chairman of BioSoteria's Board of Advisors.

The award was presented by Sally Van Doren, PharmD, President and Chief Executive Officer of BioSoteria, the conference organizer. In her comments to an audience of nearly 130 drug safety practitioners and providers, Dr. Van Doren remarked, "Hugh's thoughtful, candid and lively participation as keynote speaker and moderator at the three Pacific Drug Safety Summits has contributed to the annual event's unprecedented success."

Upon receiving the award, Dr. Tilson said, "I am especially honored by the words inscribed: 'Living the Vision.' Improving public health is my life's work, and I am pleased to support the vision of PDSS to educate drug safety professionals and create a forum for exchange of best pharmacovigilance practices."

About Hugh H. Tilson, MD, Dr.P.H., FISPE
An internationally acclaimed epidemiologist and outcomes researcher, Dr. Tilson's career in public health and preventive medicine spans forty years. He spent fifteen years in public service, including duties as a U.S. Army Preventive Medicine Officer in Germany; Consultant to the U.S. Office of Economic Opportunity, National Center for Health Services Research, and Veterans Administration; Local Public Health Officer and Human Services Director for Multnomah County in Portland, Oregon; and State Public Health Director for North Carolina.

Dr. Tilson then joined The Wellcome Foundation (now GlaxoSmithKline), where he introduced many epidemiologic principles and innovations to the private sector. Upon his retirement in 1996, he joined the full-time clinical faculty of University of North Carolina (UNC) School of Public Health in Chapel Hill. He is currently Adjunct Professor at UNC and at Duke University.

Besides serving as chairman of the BioSoteria Board of Advisors, Dr. Tilson is a member of the Board of Public Responsibility in Medicine & Research (PRIM&R) and the new national Public Health Accreditation Board (PHAB). He was a member of the Council for International Organisations for the Medical Sciences (CIOMS) Working Groups on Drug Safety from 1990 to 2001, and an advisor to the recent CIOMS VI and to the World Health Organization (WHO) Collaborating Centres. Dr. Tilson chaired the National Steering Committee for the Centers for Education and Research on Therapeutics (CERTs) program for the Agency for Healthcare Research and Quality (AHRQ) from 1999 to 2009. He served on the Institute of Medicine (IOM) report 'The Future of the Public's Health,' and most recently advised on the landmark 'Future of Drug Safety' IOM study. He is a co-editor of the first textbook of pharmacoepidemiology, now in its fourth edition as 'Pharmacoepidemiology and Therapeutic Risk Management.'

About the Pacific Drug Safety Summit (PDSS)
With a solid one-day agenda of contemporary drug safety and risk management topics, PDSS is a scientific conference held annually in the San Francisco Bay Area. What began as a small regional event in 2007 now attracts speakers, attendees, and sponsors across the U.S. and around the globe. For more information on PDSS09, please visit PDSS10 will be held on September 24, 2010, in San Francisco, CA. Details on the agenda, logistics, and sponsorship opportunities will be announced as they become available.

About BioSoteria, Inc.
BioSoteria provides innovative drug safety services and education to the biopharmaceutical industry and healthcare community. The company offers a wide range of pharmacovigilance services throughout the product lifecycle, including premarketing clinical safety surveillance, postmarketing safety monitoring, and risk management programs. BioSoteria-sponsored educational programs include the annual Pacific Drug Safety Summit and eLadder(TM) Safety, the first comprehensive drug safety training curriculum delivered in a true eLearning environment. To learn more about BioSoteria, visit the company's website at or call toll-free at 1-866-660-5553.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
Related Image:
Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit 
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 /PRNewswire/ ... innovator in modern authentication and a founding member of ... of its latest version of the Nok Nok™ S3 ... use standards-based authentication that supports existing and emerging methods ... is ideal for organizations deploying customer-facing applications that require ...
Breaking Biology News(10 mins):